KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Change in Account Payables (2016 - 2025)

Gilead Sciences (GILD) has disclosed Change in Account Payables for 17 consecutive years, with -$95.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables fell 63.79% year-over-year to -$95.0 million, compared with a TTM value of -$132.0 million through Dec 2025, down 145.52%, and an annual FY2025 reading of -$132.0 million, down 145.52% over the prior year.
  • Change in Account Payables was -$95.0 million for Q4 2025 at Gilead Sciences, down from $230.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $359.0 million in Q3 2024 and bottomed at -$272.0 million in Q1 2023.
  • Average Change in Account Payables over 5 years is -$4.0 million, with a median of -$24.5 million recorded in 2021.
  • Peak annual rise in Change in Account Payables hit 1337.93% in 2024, while the deepest fall reached 2666.67% in 2024.
  • Year by year, Change in Account Payables stood at $124.0 million in 2021, then skyrocketed by 112.9% to $264.0 million in 2022, then tumbled by 116.29% to -$43.0 million in 2023, then crashed by 34.88% to -$58.0 million in 2024, then tumbled by 63.79% to -$95.0 million in 2025.
  • Business Quant data shows Change in Account Payables for GILD at -$95.0 million in Q4 2025, $230.0 million in Q3 2025, and -$162.0 million in Q2 2025.